- Evaluation of Antiangiogenic Effects of a New Synthetic Candidate Drug KR-31831 on Xenografted Ovarian Carcinoma Using Dynamic Contrast Enhanced MRI
-
Yang J, Kim JH, Im GH, Heo H, Yoon S, Lee J, Lee JH, Jeon P
- KMID: 1116446
- Korean J Radiol.
- 2011 Oct;12(5):602-610.
- doi: 10.3348/kjr.2011.12.5.602
OBJECTIVE: The purpose of this research was to investigate the anti-angiogenic inhibitory effect of KR-31831, a newly developed anti-angiogenic agent, on an in vivo human ovarian carcinoma model using dynamic... -
- CITED
-
- Close
- SHARE
-
- Close
